thiamine

硫胺素
  • 文章类型: Journal Article
    背景:慢性心力衰竭(CHF)一直对人类的生存和健康构成重大威胁。补充硫胺素对CHF患者的疗效尚不确定。
    目的:接受补充硫胺素可能不会给CHF患者带来益处。
    方法:在Cochrane图书馆进行了全面搜索,PubMed,EMBASE,ClinicalTrials.gov,和WebofScience数据库直到2023年5月,以确定研究补充硫胺素对CHF患者的影响的文章。使用预定义的标准来选择有关研究特征和结果的数据。
    结果:七个随机分组,双盲,纳入总共274例患者的对照试验(5项平行试验和2项交叉试验).汇总这些研究的荟萃分析结果未显示与安慰剂相比,硫胺素治疗对左心室射血分数有任何显着影响(WMD=1.653%,95%CI:-1.098至4.405,p=0.239,I2=61.8%),左心室舒张末期容积(WMD=-6.831mL,95%CI:-26.367至12.704,p=0.493,I2=0.0%),6分钟步行试验(WMD=16.526m,95%CI:-36.582至69.634,p=0.542,I2=66.3%),N末端B型利钠肽前体(WMD=258.150pg/mL,95%CI:-236.406至752.707,p=0.306,I2=21.6%),或纽约心脏协会类别(WMD=-0.223,95%CI:-0.781至0.335,p=0.434,I2=87.1%)。然而,它有效地改善了硫胺素缺乏症(TD)的状况。
    结论:我们的荟萃分析表明,补充硫胺素对CHF没有直接治疗作用,除了修正TD。
    BACKGROUND: Chronic heart failure (CHF) has always posed a significant threat to human survival and health. The efficacy of thiamine supplementation in CHF patients remains uncertain.
    OBJECTIVE: Receiving supplementary thiamine may not confer benefits to patients with CHF.
    METHODS: A comprehensive search was conducted across the Cochrane Library, PubMed, EMBASE, ClinicalTrials.gov, and Web of Science databases up until May 2023 to identify articles investigating the effects of thiamine supplementation in CHF patients. Predefined criteria were utilized for selecting data on study characteristics and results.
    RESULTS: Seven randomized, double-blind, controlled trials (five parallel trials and two crossover trials) involving a total of 274 patients were enrolled. The results of the meta-analysis pooling these studies did not reveal any significant effect of thiamine treatment compared with placebo on left ventricular ejection fraction (WMD = 1.653%, 95% CI:  -1.098 to 4.405, p = 0.239, I2 = 61.8%), left ventricular end-diastolic volume (WMD = -6.831 mL, 95% CI:  -26.367 to 12.704, p = 0.493, I2 = 0.0%), 6-min walking test (WMD = 16.526 m, 95% CI:  -36.582 to 69.634, p = 0.542, I2 = 66.3%), N-terminal pro-B type natriuretic peptide (WMD = 258.150 pg/mL, 95% CI:  -236.406 to 752.707, p = 0.306, I2 = 21.6%), or New York Heart Association class (WMD = -0.223, 95% CI:  -0.781 to 0.335, p = 0.434, I2 = 87.1%). However, it effectively improved the status of thiamine deficiency (TD).
    CONCLUSIONS: Our meta-analysis indicates that thiamine supplementation does not have a direct therapeutic effect on CHF, except for correcting TD.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Letter
    暂无摘要。
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    棘阿米巴角膜炎(AK)是角膜的严重感染。由于目前可获得的化合物的无效性,预防和治疗是困难的。许多常用的化合物对棘阿米巴常规检查的影响尚未探索,但可能提供对对抗AK有用的见解。在这项研究中,我们证明了焦亚硫酸钠,眼睛护理解决方案的常见保存成分,发现浓度低于滴眼剂中常见浓度(IC500.03mg/mL)时对棘阿米巴滋养体具有活性。我们证明了焦亚硫酸钠会从生长培养基中消耗硫胺素,并且棘阿米巴是硫胺素营养缺陷型,需要硫胺素抢救才能生长。补充硫胺素可以克服焦亚硫酸钠的抑制作用。这些结果与棘阿米巴基因组中硫胺素生物合成的关键酶的缺乏相一致,使用新的或现有的化合物可能被证明是可开发的区域。的确,这项研究强调了偏亚硫酸氢钠作为一种有用的抑制剂,在体外castellanii滋养体,至少在某种程度上,通过限制可用的硫胺素。
    Acanthamoeba keratitis (AK) is a severe infection of the cornea. Prevention and treatment are difficult due to the inefficacy of currently available compounds. The impact of many commonly used compounds for routine examinations of Acanthamoeba is unexplored but might offer insight useful in combatting AK. In this study, we demonstrate that sodium metabisulfite, a common preservation constituent of eye care solutions, was found to be active against Acanthamoeba trophozoites at concentrations lower than that commonly found in eye drops (IC50 0.03 mg/mL). We demonstrate that sodium metabisulfite depletes thiamine from growth medium and that Acanthamoeba is a thiamine auxotroph, requiring thiamine salvage for growth. The inhibitory effects of sodium metabisulfite can be overcome by thiamine supplementation. These results are consistent with the lack of key enzymes for thiamine biosynthesis in the genome of Acanthamoeba, an area which might prove exploitable using new or existing compounds. Indeed, this study highlights sodium metabisulfite as a useful inhibitor of Acanthamoeba castellanii trophozoites in vitro and that it acts, at least in part, by limiting available thiamine.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:韦尼克脑病(WE)是一种由硫胺素缺乏引起的急性和潜在致命性神经精神疾病:其病因和临床表现可以是异质性的,并且被严格识别,尤其是儿童和青少年。
    方法:一名8岁女孩以共济失调步态来到急诊室,眼球震颤,和精神错乱后10天的历史反复严重呕吐;她最近的临床病史的特点是限制营养由于窒息恐惧症,导致体重大幅下降。脑磁共振成像显示,丘脑内侧区域和脑导水管周围区域的T2信号双侧增加。建立了基于临床和神经放射学结果的WE诊断,并在表现出低血清硫胺素的工作后得到证实。在精神病学评估之后,患者还被诊断为回避-限制性食物摄入障碍(ARFID),这需要开始认知行为疗法并引入阿立哌唑。患者在一个月后表现出放射学发现的改善以及她的神经症状和体征的完全缓解。
    结论:像ARFID这样的进食障碍可能会出现WE的急性症状;即使在儿科患者中,也应考虑这种可能性。特别是当非典型的神经图片或喂养问题出现时。
    BACKGROUND: Wernicke encephalopathy (WE) is an acute and potentially fatal neuropsychiatric disorder resulting from thiamine deficiency: its etiology and clinical presentation can be heterogeneous and arduously recognized, especially in children and adolescents.
    METHODS: An 8-year-old girl arrived to the emergency room with ataxic gait, nystagmus, and mental confusion after a 10-day history of repeated severe vomiting; her recent clinical history was characterized by restricted nutrition due to a choking phobia, which caused substantial weight loss. Brain magnetic resonance imaging revealed a bilaterally increased T2 signal in the medial areas of the thalami and cerebral periaqueductal region. Diagnosis of WE based on clinical and neuroradiological findings was established and confirmed after labwork showing low serum thiamine. Following psychiatric evaluation, the patient was also diagnosed with avoidance-restrictive food intake disorder (ARFID), which required starting cognitive behavioral therapy and introducing aripiprazole. The patient displayed improvement of the radiological findings after one month and complete resolution of her neurological symptoms and signs.
    CONCLUSIONS: Eating disorders like ARFID might forerun acute signs of WE; this possibility should be considered even in pediatric patients, especially when atypical neurological pictures or feeding issues come out.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:硫胺素和叶酸营养不良在失代偿性酒精性肝硬化(aLC)患者中非常常见。因此,目前的指南建议在这些患者中补充维生素。然而,实施及其对临床结局的影响尚不清楚.因此,我们旨在分析硫胺素和叶酸的使用情况及其对失代偿性aLC患者死亡率和发病率的影响.
    方法:对2011年至2023年在汉诺威医学院接受穿刺的289例失代偿性aLC连续患者进行了回顾性调查。在出院药物中评估了含有叶酸和硫胺素的补充剂的使用。对患者进行为期一年的无肝移植(LTx)生存率和肝性脑病的发生率的随访。感染和肝功能失代偿需要再次住院。
    结果:基线MELD中位数为15,中位年龄56.6岁。73.0%(n=211)为男性患者。出院时,含硫胺素补充剂和叶酸的处方为48.1%(n=139)和18.0%(n=52)的患者,分别。硫胺素和叶酸处方均与90天内改善临床结果无关。然而,在多变量分析中,叶酸摄入与较高的1年无LTx生存率相关(HR=0.48;p=0.04).此外,在多变量竞争风险模型中,叶酸替代与1年内再住院风险降低相关(HR=0.55;p=0.01).相比之下,硫胺素处方既不影响无LTx生存率,也不影响此处研究的肝脏相关并发症.
    结论:叶酸,但硫胺素替代与失代偿性aLC患者预后改善无关.
    OBJECTIVE: Thiamine and folic acid malnutrition is highly frequent in patients with decompensated alcohol-related liver cirrhosis (aLC). Current guidelines therefore recommend vitamin supplementation in these patients. However, implementation and its impact on the clinical outcome remains unknown. Therefore, we aimed to analyze the use of thiamine and folic acid and their effects on mortality and morbidity in patients with decompensated aLC.
    METHODS: A number of 289 consecutive patients with decompensated aLC who received a paracentesis at Hannover Medical School between 2011 and 2023 were retrospectively investigated. The use of folic acid and thiamine-containing supplements was assessed in the discharge medication. Patients were followed for up to one year regarding liver transplant (LTx)-free survival and the incidence of hepatic encephalopathy, infections and hepatic decompensation requiring rehospitalization.
    RESULTS: Median baseline MELD was 15, median age 56.6 years. 73.0% (n = 211) were male patients. At hospital discharge, thiamine-containing supplements and folic acid were prescribed to 48.1% (n = 139) and 18.0% (n = 52) patients, respectively. Neither thiamine nor folic acid prescription were linked to improved clinical outcomes within 90 days. However, folic acid intake was associated with a higher one-year LTx-free survival (HR = 0.48; p = 0.04) in the multivariable analysis. Furthermore, folic acid substitution was linked to a decreased risk of rehospitalization within one year (HR = 0.55; p = 0.01) in the multivariable competing risk model. In contrast, thiamine prescription did neither affect LTx-free survival nor the here investigated liver-related complications.
    CONCLUSIONS: Folic acid, but not thiamine substitution was linked to an improved outcome in patients with decompensated aLC.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Case Reports
    硫胺素是一种必需的水溶性维生素,必须通过饮食获得。这种维生素对各种生化反应至关重要,对有氧代谢至关重要。当个体缺乏硫胺素时,这可能是由于新陈代谢过度(例如在炎症中,缺血,或者营养不良,除其他原因外),厌氧代谢可用于维持能量需求。这样的化学过程产生乳酸。过量的乳酸可引起各种临床体征和症状,尽管乳酸脱氢酶(LDH)通常可以分解该化合物。以下病例是一个非常不寻常的例子,一名51岁的白人妇女提出了持续和严重腹痛的主要投诉。经过广泛的检查,排除了许多诊断和八天的住院时间,据信她可能患有硫胺素缺乏症继发的高乳酸血症,服用这种维生素后,她的病情明显改善。人们认为这可能是由于她以前的系统性红斑狼疮(SLE)诊断,血管炎,慢性炎症,和高代谢状态,除了并发LDH故障。
    Thiamine is an essential water-soluble vitamin that must be obtained through diet. This vitamin is crucial for various biochemical reactions and is vital for aerobic metabolism. When individuals are deficient in thiamine, which can be due to hypermetabolism (such as in inflammation, ischemia, or malnutrition, among other reasons), anaerobic metabolism may be utilized to maintain energy needs. Such chemical processes produce lactic acid. Excess lactic acid can cause various clinical signs and symptoms, though lactate dehydrogenase (LDH) can typically break down this compound. The following case presents a very unusual instance where a 51-year-old Caucasian woman presented with the chief complaint of ongoing and severe abdominal pain. After an extensive work-up ruling out numerous diagnoses and an eight-day hospital stay, it was believed that she may be suffering from hyperlactatemia secondary to thiamine deficiency, as she improved significantly after administration of this vitamin. It was thought that this was likely due to her previous systemic lupus erythematosus (SLE) diagnosis, vasculitis, chronic inflammation, and a hypermetabolic state, in addition to concurrent LDH malfunction.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    本研究考察了黄芪多糖(APS,传统中草药中具有降血糖功能的成分)使用体外模拟发酵模型对2型糖尿病(T2DM)患者的肠道菌群和代谢产物进行研究。分离出APS的主要成分,纯化,和结构特征。发现APS发酵可增加T2DM患者粪便微生物群中乳杆菌和双歧杆菌的丰度,并降低大肠杆菌-志贺氏菌的水平。除了增加丙酸,APS还导致全反式维甲酸和硫胺素(均具有抗氧化特性)的增加,它们在与硫胺素代谢相关的KEGG途径中的富集,等。值得注意的是,APS还可以增强粪便的抗氧化性能。相关性分析证实乳杆菌与硫胺素和DPPH清除率呈显著正相关,提示APS的抗氧化活性与其富集某些特定细菌并上调其代谢产物的能力有关。
    This study investigated the effect of astragalus polysaccharide (APS, an ingredient with hypoglycemic function in a traditional Chinese herbal medicine) on gut microbiota and metabolites of type 2 diabetes mellitus (T2DM) patients using a simulated fermentation model in vitro. The main components of APS were isolated, purified, and structure characterized. APS fermentation was found to increase the abundance of Lactobacillus and Bifidobacterium and decrease the Escherichia-Shigella level in the fecal microbiota of T2DM patients. Apart from increasing propionic acid, APS also caused an increase in all-trans-retinoic acid and thiamine (both have antioxidant properties), with their enrichment in the KEGG pathway associated with thiamine metabolism, etc. Notably, APS could also enhance fecal antioxidant properties. Correlation analysis confirmed a significant positive correlation of Lactobacillus with thiamine and DPPH-clearance rate, suggesting the antioxidant activity of APS was related to its ability to enrich some specific bacteria and upregulate their metabolites.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    Various diseases of the peripheral nervous system are associated with metabolic disorders of B vitamins. A lack of neurotropic vitamins, which began in the early stages of the development of a bacterial disease, led to its more rapid development. The article analyzes data on B vitamin deficiency in the pathogenesis of the most dangerous diseases of the peripheral nervous system. Information is provided about the dangers of the clinical use of the drug Combilipen for the treatment of such patients.
    Различные заболевания периферической нервной системы ассоциированы с нарушениями обмена витаминов группы B. Недостаток в организме нейротропных витаминов способствует раннему появлению клинических проявлений заболевания, его более быстрому прогрессированию. В статье анализируются данные о роли дефицита витаминов группы B в патогенезе наиболее распространенных заболеваний периферической нервной системы. Приведены сведения о результатах изучения клинического применения препарата Комбилипен для лечения таких больных.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:本系统评价旨在评估氢化可的松的疗效和安全性,抗坏血酸,和硫胺素(HAT)联合治疗脓毒症和脓毒性休克患者。
    方法:我们在MEDLINE中进行了数据库搜索,Embase,中部,WebofScience,和CNKI文献,比较脓毒症/脓毒性休克患者的HAT与安慰剂/标准护理或氢化可的松。结果包括死亡率,ICU/住院时间(LOS),血管升压药持续时间,机械通气持续时间,72小时时SOFA的变化,和不良事件。RCT结果汇集在随机效应荟萃分析中。使用GRADE评估证据质量。
    结果:纳入了15个随机对照试验(N=2,594)。在72小时,与安慰剂/SoC相比,HAT降低了基线的SOFA评分(平均差[MD]-1.16,95%置信区间[CI]:-1.58至-0.74,I2=0%),基于中等质量的证据。HAT还减少了血管加压药使用的持续时间(MD-18.80小时,95%CI:-23.67至-13.93,I2=64%)与安慰剂/SoC相比,基于中等质量的证据。HAT增加了医院LOS(MD2.05天,95%CI:0.15-3.95,I2=57%)与安慰剂/SoC相比,基于非常低的证据质量。与安慰剂/SoC相比,HAT没有增加不良事件的发生率。
    结论:HAT似乎有利于减少脓毒症/脓毒性休克患者的血管加压药使用和改善器官功能。然而,与单独使用氢化可的松相比,其优势尚不清楚.未来的研究应使用氢化可的松比较器,并区分败血症特异性和合并症或戒断相关的死亡率。
    BACKGROUND: This systematic review aimed to assess the efficacy and safety of hydrocortisone, ascorbic acid, and thiamine (HAT) combination therapy in patients with sepsis and septic shock.
    METHODS: We conducted a database search in MEDLINE, Embase, CENTRAL, Web of Science, and CNKI for randomised controlled trials (RCTs) comparing HAT against placebo/standard of care or against hydrocortisone in sepsis/septic shock patients. Outcomes included mortality, ICU/hospital length of stay (LOS), vasopressor durations, mechanical ventilation durations, change in SOFA at 72 h, and adverse events. RCT results were pooled in random-effects meta-analyses. Quality of evidence was assessed using GRADE.
    RESULTS: Fifteen RCTs (N = 2,594) were included. At 72 h, HAT reduced SOFA scores from baseline (mean difference [MD] -1.16, 95% confidence interval [CI]: -1.58 to -0.74, I2 = 0%) compared to placebo/SoC, based on moderate quality of evidence. HAT also reduced the duration of vasopressor use (MD -18.80 h, 95% CI: -23.67 to -13.93, I2 = 64%) compared to placebo/SoC, based on moderate quality of evidence. HAT increased hospital LOS (MD 2.05 days, 95% CI: 0.15-3.95, I2 = 57%) compared to placebo/SoC, based on very low quality of evidence. HAT did not increase incidence of adverse events compared to placebo/SoC.
    CONCLUSIONS: HAT appears beneficial in reducing vasopressor use and improving organ function in sepsis/septic shock patients. However, its advantages over hydrocortisone alone remain unclear. Future research should use hydrocortisone comparators and distinguish between sepsis-specific and comorbidity- or care-withdrawal-related mortality.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    硫胺素是一种重要的营养素,可作为主要位于线粒体中的几种酶的辅因子。这些硫胺素依赖性酶参与能量代谢,核酸生物合成,和抗氧化机械。酶HMP-P激酶/硫胺素一磷酸合酶(TH1)在硫胺素生物合成中占有关键地位,负责HMP-P磷酸化为HMP-PP以及HMP-PP和HET-P缩合形成TMP。通过数学动力学模型,我们已经确定TH1是水稻硫胺素生物强化的关键参与者。我们进一步关注OsTH1的功能表征。序列和基因表达分析,随着系统发育研究,提供了对OsTH1双功能特征和进化的见解。OsTH1在硫胺素生物合成中不可或缺的作用通过OsTH1的异源表达和在硫胺素生产中受损的酵母敲除突变体的成功互补得到了验证。我们还证明,在水稻愈伤组织中单独过表达OsTH1显著提高了B1浓度,导致硫胺素积累增加50%。我们的研究强调了OsTH1在硫胺素生物合成中的关键作用,阐明其双功能性质和进化意义。OsTH1过表达后,水稻愈伤组织中硫胺素的积累显着增加,这证明了其在生物强化策略中的潜在应用。
    Thiamin is a vital nutrient that acts as a cofactor for several enzymes primarily localized in the mitochondria. These thiamin-dependent enzymes are involved in energy metabolism, nucleic acid biosynthesis, and antioxidant machinery. The enzyme HMP-P kinase/thiamin monophosphate synthase (TH1) holds a key position in thiamin biosynthesis, being responsible for the phosphorylation of HMP-P into HMP-PP and for the condensation of HMP-PP and HET-P to form TMP. Through mathematical kinetic model, we have identified TH1 as a critical player for thiamin biofortification in rice. We further focused on the functional characterization of OsTH1. Sequence and gene expression analysis, along with phylogenetic studies, provided insights into OsTH1 bifunctional features and evolution. The indispensable role of OsTH1 in thiamin biosynthesis was validated by heterologous expression of OsTH1 and successful complementation of yeast knock-out mutants impaired in thiamin production. We also proved that the sole OsTH1 overexpression in rice callus significantly improves B1 concentration, resulting in 50% increase in thiamin accumulation. Our study underscores the critical role of OsTH1 in thiamin biosynthesis, shedding light on its bifunctional nature and evolutionary significance. The significant enhancement of thiamin accumulation in rice callus upon OsTH1 overexpression constitutes evidence of its potential application in biofortification strategies.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号